4//SEC Filing
Brown Douglas Matthew 4
Accession 0001077183-22-000054
CIK 0001077183other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 7:07 PM ET
Size
8.9 KB
Accession
0001077183-22-000054
Insider Transaction Report
Form 4
Brown Douglas Matthew
Chief Strategy Officer
Transactions
- Award
Common Stock
2022-04-01+82,305→ 158,684 total
Holdings
- 45,017
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (45,017 underlying) - 85,519
Stock Option (Right to Buy)
Exercise: $21.41Exp: 2029-03-01→ Common Stock (85,519 underlying) - 26,378
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (26,378 underlying)
Footnotes (4)
- [F1]On April 1, 2022, Mr. Brown was granted 82,305 restricted stock awards. These awards vest on the first anniversary date of the grant date.
- [F2]On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 1, 2022, Mr. Brown was granted 85,519 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001849414
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 7:07 PM ET
- Size
- 8.9 KB